New diet drug wins FDA panel approval: 1st new diet drug in 13 years

A new diet drug leaped another hurdle in its progress to becoming the first weight loss prescription drug approved in the past 13 years, reported the New York Times yesterday. The F.D.A.'s advisory panel agreed in their vote that lorcaserin's benefits outweighed the drug's risks. A fat reduction review can help you construct a clear describe of what you demand to focus on to accomplish your fat burning objective if you're a novice; or serve as a reminder for these who are at an advanced or more enhance stage of their weight loss strategy. Applying are seven steps that can serve as methods for your special weight loss program. The first thing that one must understand is that losing weight and losing fat is not a similar thing. Many weight loss applications have misled people into thinking that it is the same, but most diets and weight loss plans only work by producing a person's body to lose more muscle cells and water than actual body fat, more help please visit The Fat Loss Factor. The FDA is scheduled to approve it by June 27. Although the agency does not have to follow the panel's recommendations, it typically does, according to the Times.

Qnexa, another prescription weight loss medication, was endorsed in February. The FDA has until July 1 to decide whether that drug will be approved as well. Dr. Oz created an entire show based on Qnexa, evaluating whether the weight loss medication had the potential to help people shed the pounds more easily. Click here to read about that show and his views.

In a related article published yesterday, Forbes noted that battling fat has become "a key priority for public health agencies. The percentage of obese Americans, which is already a hefty 36 percent, is expected to swell to 42 percent by 2030. And by then, 11 percent could be severely obese, which is deemed to be about 100 or more pounds over a healthy weight, compared with 6 percent two years ago." If these new drugs are approved, they will be added to what is already a $20 billion weight loss industry annually.

• 
  

  May 07, 2013 - Daily Dose - HealthCentral.com - Trusted, Reliable ...

  www.healthcentral.com Daily Dose

  A new treatment just may make gray hair a thing of the past. A team of European researchers has figured out how to counteract the natural build up of hydrogen ...

• Pharmaceutical News and Articles - Drugs.com Prescription Drug ...

  www.drugs.com/news

  Pharmaceutical news from Drugs.com. Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

• Belviq (lorcaserin hydrochloride) Diet Pills.

  www.lorcaserinpill.com

  Discover more about a possible new prescription diet pill showing very little side effects and the promise of effective weight loss.

  Careful!

  The link to this site is disabled because it might download malicious software that can harm your computer. Learn MoreWe suggest you choose another result, but if you want to risk it, visit the website.

• CorDynamics: Cardiovascular Focus PreClinical Drug

  https://www.facebook.com/CorDynamics

  CorDynamics: Cardiovascular Focus PreClinical Drug Development Expertise, Chicago, IL. 140 likes 0 talking about this.

• Orlistat - Wikipedia, the free encyclopedia

  en.wikipedia.org/wiki/Orlistat

  Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity. It is marketed as a prescription under the trade name Xenical by Roche in most ...

• DRUG DEVELOPMENT: - Homepage - The Burrill Report

  www.burrillreport.com/index.html

  The Burrill Report ... Worldwide prescription drug sales in dollar terms fell for the first time in 2012, a result of competition from generic drugs, price controls ...

• FDA May Approve New Diet Pill Qnexa Fox News Latino

  latino.foxnews.com/.../health/2012/02/23/fda-may-approve-new-diet-pill

  Feb 23, 2012 A new diet pill is one step closer to gaining FDA approval, and, if approved, Qnexa would be the first new prescription diet pill approved in 13 years.

• FDA

  www.fda.gov News & Events Newsroom

  June 2013 June 29, 2013 - FDA to detain pomegranate seeds offered for import from Goknur of Turkey; June 28, 2013 - FDA approves the first non-hormonal treatment for ...

• Aspartame - Wikipedia, the free encyclopedia

  en.wikipedia.org/wiki/Aspartame

  Aspartame (APM) is an artificial, non- saccharide sweetener used as a sugar substitute in some foods and beverages. In the European Union, it is codified as E951.

• AEGiS

  www.aegis.org/en

  Little Solace for AIDS Victims on the Drug Front The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter ...